Why the Pro Medicus Limited (ASX:PME) share price is rocketing higher today

The Pro Medicus Limited (ASX:PME) share price has rocketed higher in morning trade after announcing a major deal with Partners Healthcare in the United States…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The market may be sinking lower again today but the same cannot be said for the Pro Medicus Limited (ASX: PME) share price.

In morning trade the health imaging company's shares have rocketed over 10% higher to $10.11 following the announcement of a major new deal.

What was announced?

This morning Pro Medicus announced that its wholly-owned U.S. subsidiary, Visage Imaging, has signed a A$27 million, 7-year contract with Partners Healthcare.

Partners Healthcare is the largest health system in the state of Massachusetts and one of the largest and most respected health providers in North America.

According to the release, the contract is based on a transaction licensing model and will see Pro Medicus' Visage 7 technology implemented at Partners' two flagship hospitals, Massachusetts General Hospital and Brigham and Women's Hospital, eliminating their legacy PACS. It also includes scope to expand to other Partners network hospitals at a later date.

Pro Medicus CEO, Dr Sam Hupert, believes the deal is a milestone for Pro Medicus and that it is a testament to the quality of its technology.

He said: "Not only is it our biggest deal to date, there is the potential for further upside within the Partners network after this initial rollout is completed."

Before adding that these hospitals are: "two of the most prestigious medical institutions in North America renowned for their medical research, as well as their key roles as teaching hospitals for Harvard Medical School. The fact that both institutions selected Visage 7 as their platform of choice reinforces our view that Visage's leading edge technology is suitable for a broad range of clinical environments, including the most sophisticated and demanding users."

Should you invest?

While Pro Medicus' shares are certainly expensive, I believe deals like this demonstrate the enormous potential that the company has and why it could prove to be a great long-term buy and hold investment along with fellow healthcare technology companies Nanosonics Ltd (ASX: NAN) and Volpara Health Technologies Ltd (ASX: VHT).

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited, Pro Medicus Ltd., and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup.
Share Gainers

Here are the top 10 ASX 200 shares today

Another day, another loss for investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Capstone Copper, Gentrack, Mineral Resources, and WiseTech shares are racing higher today

These shares are avoiding the market weakness and pushing higher. Let's find out why.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another rough day for the markets this Wednesday.

Read more »

people looking through comical glasses, what to look for, reporting season, person thinking, person interested
Share Gainers

Are APA shares a buy after reaching a three-year high?

Can the share price keep storming higher in 2026?

Read more »

A service station attendant crosses his arms and smiles towards the camera with a backdrop of petrol bowsers and a drive-through facility.
Energy Shares

Ampol shares surge 50% to a two-year high: Buy, sell or hold?

Find out what upside analysts are tipping for Ampol shares next.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why 29Metals, Aurelia Metals, Codan, and oOhMedia shares are racing higher today

These shares are faring better than most on hump day. What's going on?

Read more »

A male ASX investor on the street wearing a grey suit clenches his fist and yells yes after seeing on his ipad that the Paladin share price is going up again today
Share Market News

If I'd put $6K in this ASX mining stock 12 months ago I'd have over $20k now

Analysts tip the ASX miner's share price to climbing higher over the next 12 months.

Read more »